Prevnar 13 In Older Adults Appears To Have Smooth Path To FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee to give recommendations on the Pfizer vaccine’s safety and immunogenicity using accelerated approval, but no votes mentioned.